Patent · US Active

Process for the expression of peptides of interest using GCSF as a fusion partner

US8507221B2 · kind B2 · utility

0Cited by
0References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2008
Grant dateAug 13, 2013
Priority date
Expiry dateJul 28, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P21/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention discloses an improved process for the production of desired recombinant peptides from bacterial cells by using G-CSF as a novel fusion partner for their high level expression in these cells. The invention further provides an expression system comprising the fusion protein wherein the G-CSF is operatively linked to the peptide of interest via an enzymatic or chemical cleavage site which can be used to separate the fusion partner from the said peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.